BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Staging
2413 results:

  • 1. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
    Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
    Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multimodal Approaches to Patient Selection for Pancreas cancer Surgery.
    Muaddi H; Kearse L; Warner S
    Curr Oncol; 2024 Apr; 31(4):2260-2273. PubMed ID: 38668070
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Defining distal splenopancreatectomy by the mesopancreas.
    Safi SA; Alexander A; Neuhuber W; Haeberle L; Rehders A; Luedde T; Esposito I; Fluegen G; Knoefel WT
    Langenbecks Arch Surg; 2024 Apr; 409(1):127. PubMed ID: 38625602
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
    Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
    Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 6. Sentinel Node Mapping in Ovarian Tumors: A Study Using Lymphoscintigraphy and SPECT/CT.
    Ataei Nakhaei S; Sadeghi R; Mostafavi SM; Treglia G; Hassanzadeh M; Esmaeilpour M; Taheri NS; Farazestanian M
    Contrast Media Mol Imaging; 2024; 2024():5453692. PubMed ID: 38435483
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Perioperative factors associated with survival following surgery for pancreatic cancer - a nationwide analysis of 473 cases from Denmark.
    Spore LM; Dencker EE; Kvanner EA; Hansen CP; Burgdorf SK; Krohn PS; Kollbeck SLG; Storkholm JH; Sillesen M
    BMC Surg; 2024 Mar; 24(1):76. PubMed ID: 38431571
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
    Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
    Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study.
    Zhang J; Li M; Feng L; Zhai Y; Wang L; Chen Y
    World J Surg Oncol; 2024 Feb; 22(1):62. PubMed ID: 38389046
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
    Soll D; Bischoff P; Frisch A; Jensen M; Karadeniz Z; Mogl MT; Horst D; Penzkofer T; Spranger J; Keilholz U; Mai K
    BMC Endocr Disord; 2024 Feb; 24(1):25. PubMed ID: 38383419
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma.
    Jannello LMI; Morra S; Scheipner L; Baudo A; Siech C; de Angelis M; Touma N; Tian Z; Goyal JA; Luzzago S; Mistretta FA; Piccinelli ML; Saad F; Chun FKH; Briganti A; Ahyai S; Carmignani L; Longo N; de Cobelli O; Musi G; Karakiewicz PI
    Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38363202
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
    Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
    Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
    Mokarram Dorri N; Del M; Cannone F; Lefebvre M; Loaec C; Sabiani L; Jauffret C; Blache G; Houvenaeghel G; Carcopino X; Classe JM; Narducci F; Martinez A; Lambaudie E
    Eur J Surg Oncol; 2024 Mar; 50(3):107976. PubMed ID: 38354484
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of prophylactic central lymph node dissection on the complications and recurrence rates in papillary thyroid carcinoma-An AFCE (French-speaking Association of endocrine Surgery) multicentre study based on the EUROCRINE® national data.
    Chereau N; Christou N; Caiazzo R; Le Fouler A; Lifante JC; Maillard L; Mirallie E; Pattou F; Bouviez N; Santucci N; Brunaud L; Menegaux F
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1993. PubMed ID: 38351532
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Split-bolus single-phase versus single-bolus split-phase CT acquisition protocols for staging in patients with testicular cancer: A retrospective study.
    O'Regan PW; Dewhurst C; O'Mahony AT; O'Regan C; O'Leary V; O'Connor G; Ryan D; Maher MM; Young R
    Radiography (Lond); 2024 Mar; 30(2):628-633. PubMed ID: 38330895
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Improved Clinical staging System for Localized Pancreatic cancer Using the ABC Factors: A TAPS Consortium Study.
    Dekker EN; van Dam JL; Janssen QP; Besselink MG; DeSilva A; Doppenberg D; van Eijck CHJ; Nasar N; O'Reilly EM; Paniccia A; Prakash LR; Tzeng CD; Verkolf EMM; Wei AC; Zureikat AH; Katz MHG; Groot Koerkamp B;
    J Clin Oncol; 2024 Apr; 42(12):1357-1367. PubMed ID: 38315954
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
    Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
    Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The American Thyroid Association risk classification of papillary thyroid cancer according to presurgery cytology.
    Croce L; Teliti M; Chytiris S; Sparano C; Coperchini F; Villani L; Calì B; Petrone L; Magri F; Trimboli P; Rotondi M
    Eur J Endocrinol; 2024 Feb; 190(2):165-172. PubMed ID: 38298148
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Trends and disparities in access to minimally invasive distal pancreatectomy (midp): an eight-year analysis from the national cancer database.
    Jehan FS; Khreiss M; Seth A; Aziz H
    J Robot Surg; 2024 Jan; 18(1):52. PubMed ID: 38280048
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
    Katsanevakis E; Addo-Yobo W; Bharathan B; Loona A; Gan C; Nunns D; Gajjar K
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():105-110. PubMed ID: 38237307
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 121.